apl. Prof. Dr. Luitpold Distel

Einrichtungen, die zum Universitätsklinikum Erlangen gehören Medizinische Fakultät Department of Radiation Oncology

Mechanism of necrotic Cell Clearance by non-professional Phagocytes (2018) Hofmann A, Seeberg J, Fietkau R, Distel L Conference contribution Proliferating non-professional Phagocytes are able to generate Cell-in-Cell Structures (2018) Hofmann A, Seeberg J, Fietkau R, Distel L Conference contribution Kinase Inhibitor Palbociclib shows differential Effects upon Irradiation on Normal Tissue and Cancer Cell Lines (2018) Jost T, Proebstle S, Buerkel F, Hecht M, Fietkau R, Distel L Conference contribution Older Patients Are Less Affected by Radiochemotherapeutic Treatment than Younger (2018) Welling MJ, Losensky W, Wächter K, Schilling T, Frank F, Haas M, Fietkau R, et al. Journal article Rate of individuals with clearly increased radiosensitivity rise with age both in healthy individuals and in cancer patients (2018) Schuster B, Ellmann A, Mayo T, Auer J, Haas M, Hecht M, Fietkau R, Distel L Journal article Inflammatory cells infiltrating HPV positive and negative head and neck squamous cell carcinoma (2018) Distel L, Farhoumand D, Haderlein M, Fietkau R Conference contribution Effect of the kinase-inhibitor Palbociclib on radio-therapeutic treatment in a 3D cell culture model (2018) Jost T, Hecht M, Fietkau R, Distel L Conference contribution Enhancing the Effect of Combination Therapy with the PARP Inhibitor Talazoparib and ionizing Radiation on Melanoma Cell Lines (2018) Proebstle S, Jost T, Buerkel F, Hecht M, Fietkau R, Distel L Conference contribution Investigation of a radioprotective Effect of the Kinase Inhibitor Palbociclib on Melanoma Cells in a 3D Cell Culture Model (2018) Jost T, Buerkel F, Proebstle S, Hecht M, Fietkau R, Distel L Conference contribution Inflammatory Cells in HPV positive and negative Head and Neck Tumors (2018) Distel L, Haderlein M, Farhoumand D, Fietkau R, Hecht M Conference contribution